957344-74-0

Basic information

• Product Name: 5,8-DibroMoiMidazo[1,2-a]pyrazine
• Synonyms: 5,8-DibroMoiMidazo[1,2-a]pyrazine
• CAS NO: 957344-74-0
• Molecular Formula: C₆H₃Br₂N₃
• Molecular Weight: 276.91612
• Mol File: 957344-74-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Density: 2.35±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.30±0.30(Predicted)
• CAS DataBase Reference: 5,8-DibroMoiMidazo[1,2-a]pyrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 5,8-DibroMoiMidazo[1,2-a]pyrazine(957344-74-0)
• EPA Substance Registry System: 5,8-DibroMoiMidazo[1,2-a]pyrazine(957344-74-0)

Safety Data

• Hazardous Substances Data: 957344-74-0(Hazardous Substances Data)

Usage

General Description

5,8-dibromoimidazo[1,2-a]pyrazine is a chemical compound with the molecular formula C6H2Br2N2. It is a heterocyclic aromatic compound that contains two bromine atoms and belongs to the imidazo[1,2-a]pyrazine family. 5,8-dibromoimidazo[1,2-a]pyrazine has been identified as a potential building block for various pharmaceutical and agrochemical products due to its unique chemical and physical properties. 5,8-dibromoimidazo[1,2-a]pyrazine has shown promising biological activities, making it valuable for the development of new drugs and synthetic pathways. Overall, this compound has garnered interest in the scientific community for its potential applications in medicinal and agricultural chemistry.

Upstream product

• 957230-70-5 3,6-dibromopyrazin-2-amine 
• 17157-48-1 bromoacetaldehyde 
• 2032-35-1 Bromoacetaldehyde diethyl acetal 

Downstream Products

• 957344-77-3 (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-(4-chloro-phenyl)-amine 
• 1169391-98-3 4-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino)-N-(2-diethylaminoethyl)benzenesulfonamide 
• 957344-95-5 (5-bromoimidazo[1,2-a]pyrazin-8-yl)-(4-(4-methylpiperazin-1-yl)phenyl)amine 
• 957345-26-5 (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-[4-(1-methyl-piperidin-4-ylmethoxy)-phenyl]-amine 
• 957345-77-6 4-(5-bromo-imidazo[1,2-a]pyrazin-8-ylamino)-2-methoxy-N-(6-methylpyridin-3-ylmethyl)benzamide 
• 1169533-32-7 (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-[4-(1-isopropylpiperidin-4-yl)-phenyl]amine 
• 957345-90-3 (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-amine 
• 957346-50-8 (5-bromoimidazo[1,2-a]pyrazin-8-yl)-4-(4-morpholino-4-ylphenyl)amine 
• 957346-43-9 4-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino)benzoic acid 
• 1169393-38-7 4-(5-bromoimidazo[1,2-a]pyrazin-8-ylamino)-N-(4-hydroxybenzyl)benzamide 

Relevant articles and documents

FUSED PYRAZINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON TAK1

A compound selected from pyrazine fused-ring derivatives of a chemical formula 1 or pharmaceutically acceptable salts thereof has excellent inhibition activity with respect to TAK1 kinase. A pharmaceutical composition comprising the same is capable of increasing activity of anticancer drugs with respect to cancer or tumor by inhibiting activation of TAK1 kinase, with excellent effects as a prevention agent or a therapeutic agent of cancer or tumor. In the chemical formula 1, A, X, Y, W, Z, E, R^1, and m are the same as defined in the specification.COPYRIGHT KIPO 2016

FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel[1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.